National Research (NASDAQ: NRC) — Company Overview, News & Financial Data
National Research specializes in healthcare analytics to enhance patient experiences and operational efficiency.
National Research
National Research (NASDAQ:NRC) specializes in healthcare analytics and solutions, aiming to enhance patient experiences, improve outcomes, and foster organizational growth. It operates primarily in the healthcare sector, delivering comprehensive insights and data analysis to healthcare providers, payers, and pharmaceutical companies. National Research's projects range from patient satisfaction surveys to advanced healthcare analytics, with objectives focused on leveraging data to improve the quality of care, patient engagement, and operational efficiency. The company's innovative approaches help clients navigate the complexities of the healthcare landscape and achieve sustainable growth. National Research's commitment to excellence and customer service underscores its mission to transform healthcare through evidence-based solutions and actionable insights.
Snapshot
Operations
Products and/or services of National Research
- Customer feedback analysis and improvement solutions for healthcare providers.
- Patient safety and risk management tools designed to ensure healthcare quality and compliance.
- Employee engagement solutions targeting productivity and retention in healthcare settings.
- Market insights services to guide healthcare organizations in strategic decision making.
- Physician alignment and engagement tools to optimize collaboration and care delivery.
- Post-acute care insights and analytics to support patient transitions and outcomes.
National Research executive team
- Michael D. HaysFounder & Chairman
- Trent S. GreenCEO, Principal Executive Officer & Director
- Helen L. HrdyEVP & COO
- Andrew MonnichEVP & Chief Corporate Development Officer
- Jason R. RauExecutive Vice President of Sales
- Jordan N. FreemanChief Accounting Officer
- Jennifer BaronChief Experience Officer
- David BurikExecutive Vice President of Strategic Insights
Latest news about National Research
Dividend history
Dividends per share paid by National Research , by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $0.6400 |
| FY2025 | — | — | — | $0.5200 |
| FY2024 | — | — | — | $0.4800 |
| FY2023 | — | — | — | $1.4800 |
| FY2022 | — | — | — | $0.8400 |
Key financials
Reported results for National Research , in USD.
- Market cap
- 510.8M
- Revenue (TTM)
- 143.8M
- P/E ratio
- 89.1
- EPS (diluted, TTM)
- 0.3
- Dividend yield
- 2.6%
- Profit margin
- 4.5%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 137.4M | 22.6M | 11.6M | |
| 143.1M | 35.2M | 24.8M | |
| 148.6M | 40M | 31M | |
| 151.6M | 46.5M | 31.8M |